China Resources Pharmaceutical Group Limited_Providing professional financial news and data related to China Resources Pharmaceutical Group Limited, committed to creating a comprehensive and efficient information access channel for users | NewTimeSpace

China Resources Pharmaceutical Group Limited (03320.HK): Plans to Acquire 23.50% Equity Stake in Lier Chemical at Consideration of Approximately RMB 5.656 Billion

Tags：

China Resources Pharmaceutical Group Limited 03320.HK

2026-07-30

Finance
MicroPort NeuroScienti c Corporation (02172.HK): Artemis Dream® Self-expanding Intracranial Sirolimus-eluting Stent System Enters NMPA Innovative Medical Device Fast Track
Finance
IMAGI INTERNATIONAL (00585.HK): Appointment of Wang Haomian as Executive Director and Group Vice President
Finance
Jiangsu Hengrui Pharmaceuticals (01276.HK): HRS5580 for Injection Obtains Clinical Trial Approval Notice
Finance
COSCO SHIPPING Development (02866.HK): Plans to Apply for Registration and Issuance of Corporate Bonds with a Ceiling of RMB 6 Billion
Finance
Dynasty Digital Holdings (00451.HK): Cancellation of Second Tranche Subscription Shares
Finance
Jiangsu Hengrui Pharmaceuticals (01276.HK): Insulin Sudelidec Injection Approved for Marketing by NMPA
Finance
Peking University Resources (00618.HK): Termination of Joint Venture Establishment
Finance
DAIDO GROUP (00544.HK): Subscription for New Shares Under General Mandate to Raise HK$10 Million
Finance
China Resources Pharmaceutical Group Limited (03320.HK): Plans to Acquire 23.50% Equity Stake in Lier Chemical at Consideration of Approximately RMB 5.656 Billion
Finance
JST Group (06687.HK): Expected to Swing to Profit in Interim Period, Adjusted Net Profit Projected to Surge by 227% to 285%

Scan QR Code

Download App